Coronavirus Diamond Princess Remdesivir

February 25: NIH Announces Trial Of Remdesivir

The National Institute of Health announced on Tuesday that a trial of the drug remdesivir was underway in Nebraska, with the first patient a passenger who was aboard the Diamond Princess.

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is theĀ National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. This is the first clinical trial in the United States to evaluate an experimental treatment for COVID-19, the respiratory disease first detected in December 2019 in Wuhan, Hubei Province, China.


Leave a Reply

Your email address will not be published. Required fields are marked *